The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 4.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 18%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (21 analysts) rates it buy, with a mean price target of $102.
Oneok
OKE · a US exchange · USD · Market cap $55.1B · 6,326 employees
ONEOK, Inc.
FAIL · Does not pass the screenPrice as of 19 Nov 2026Daily close, not a live quote
Screened 2026-11-19 · the tape above runs as of 08:05 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price86.52 USD at the 19 Nov 2026 close
- Our value readOvervalued vs our fair value, as of 19 Nov 2026
- Our regime readDistribution, as of 15 Nov 2026
- Ethical screenDoes not pass
- OptionsOpen interest leans to puts (put/call 1.18)
- Last reviewed19 Nov 2026 (1 day ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: $75.86 to $87.24, base estimate $75.86 (screen dated 2026-11-19).
- Trend Distribution
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options put/call open interest 1.18, read 2026-11-19
- Ethical does not pass the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its distribution label.
Oneok holds its Distribution at $86.52. The statistical read favours the sellers, held for 353 days.
| Phase | Distribution · caution |
| Quantitative state | The statistical read favours the sellers, held for 353 days |
| Price at the screen | $86.52 |
| Valuation | 13.57 trailing · 14.27 forward price to earnings |
| Values screen | FAIL · score 10.0 |
| Beta | 0.74 |
Five Screens: OKE's Results
FAIL. Debt ratio
| Test | Figure | Limit | Status |
|---|---|---|---|
| Business activity | Permissible | Permissible core business | Pass |
| Debt load | 49.24% | Below 33% | Fail |
| Interest-bearing cash | 4.34% | Below 33% | Pass |
| Receivables | 4.63% | Below 49% | Pass |
| Revenue purity | 0.10% | Below 5% | Pass |
Definitions, sources and threshold rules: ticker values-screen methodology.
The Ethical ReadWhy It Falls Short, in Plain English
Oneok's business is in a permissible area, but its interest-bearing debt is about 49% of the company, well over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-11-19. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when OKE's ethical verdict changes
Today OKE does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Fair Value Range
Our analysis reads Overvalued vs our fair value, as of 19 Nov 2026: it trades above our $75.86 fair value estimate, moderate competitive moat, 44.30% revenue growth.
Model construction and limits: fair-value methodology.
Fair value range in USD, drawn from the 2026-11-19 screen. The gold marker is the market price at the same screen. The price runs 14.1% above the base estimate.
Third-party analyst targets: 21 covering, consensus Buy. The average target sits +16% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & ProjectionsWhere our models see it going: fair-value estimate $75.86, with a range of $75.86 to $87.24, dated to the 2026-11-19 screen.
How our estimate and third-party targets differ.
The Business, in Plain WordsMidstream cash flows hide a heavy debt burden
Every day gas moves through Oneok's network and the fees keep coming in. Yet the company trades well above our fair value with a negative margin of safety and a forward multiple that does not reflect the cyclical nature of energy volumes.
We pass because the ethical screen flags excessive debt and the business sits in a sector prone to boom and bust earnings. Revenue growth of twenty percent looks strong on the surface, yet profit margins of ten percent and a sixteen percent return on equity do not justify stretching valuations when downturns can erase those gains quickly.
Analysts may cluster around a higher target, but peak cycle earnings often produce low multiples that later prove expensive. Debt remains the core concern and leaves little room if volumes or prices turn. Analysis, not advice.
| Forward P/E | 14.3xcheap for a company growing this fast |
| Trailing P/E | 13.6xreasonably valued |
| EPS, trailing | 6.44 |
| EPS, forward | 6.12 |
| Revenue growth | +44.3%growing very fast |
| Profit margin | 9.4%thin but positive margins |
| Return on equity | 15.0%a solid return on shareholder capital |
| FCF yield | 1.41% |
| Dividend yield | 4.88% |
| Debt to equity | 0.88moderate, manageable leverage |
| Current ratio | 0.84below 1: short-term bills exceed liquid assets |
| Beta | 0.74steadier than the market |
| Short interest, float | 0.04% |
| 52-week range | 68.10 - 99.85 |
| Moat | MODERATE |
| Market cap | $55.1B |
| Employees | 6,326 |
Metric definitions and interpretation rules: ticker-page methodology.
Every Entry, As Written
The framework has shifted from accumulation to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 11.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 18%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (20 analysts) rates it buy, with a mean price target of $103.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 7.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 13% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 18%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (20 analysts) rates it buy, with a mean price target of $102.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 13% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 18%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (20 analysts) rates it buy, with a mean price target of $101. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 13% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 18%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (20 analysts) rates it buy, with a mean price target of $101. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 11% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 18%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (20 analysts) rates it buy, with a mean price target of $101. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 11% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 18%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (20 analysts) rates it buy, with a mean price target of $101. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 11% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 18%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (20 analysts) rates it buy, with a mean price target of $101. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 11% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 18%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (20 analysts) rates it buy, with a mean price target of $101. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 11% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 18%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (20 analysts) rates it buy, with a mean price target of $101. It reported earnings in this window, a natural checkpoint for the thesis.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- 3 Pipeline Dividends Built for a Roth IRA, and Why Pipeline Partnerships May Not Be Yahoo Finance · 2d ago
- ONEOK or Kimberly-Clark: I Can Only Pick One Dividend Stock for the Next 20 Years. Here’s Mine Yahoo Finance · 2d ago
- GSK or ONEOK: I Can Only Pick One Dividend Stock for the Next 10 Years. Here’s Mine Yahoo Finance · 2d ago
- 5 Oil and Gas Stocks That Crushed Third-Quarter Earnings Estimates Yahoo Finance · 2d ago
- What Is Devon Getting For All That Spending? Yahoo Finance · 4d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-20 | HULSE WALTER S III | Chief Financial Officer | 7,739 | · | |
| 2026-02-20 | BURDICK KEVIN L | Officer | 5,628 | · | |
| 2026-02-20 | SWORDS SHERIDAN C | Officer | 4,924 | · | |
| 2026-02-20 | SPEARS MARY M. | Officer | 2,285 | · | |
| 2026-02-20 | NORTON PIERCE H II | Chief Executive Officer | 17,588 | · | |
| 2026-02-20 | TAYLOR LYNDON C | Officer | 8,538 | · | |
| 2026-01-30 | LENTZ RANDY N. | Chief Operating Officer | 6,556 | · | |
| 2026-01-23 | OWODUNNI PRECIOUS WILLIAMS | Director | 727 | $56,706 | |
| 2026-01-23 | MCCOLLUM MARK A | Director | 727 | $56,706 | |
| 2025-11-03 | DERKSEN BRIAN LLOYD | Director | 2,500 | $165,000 |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-09-11 | Kevin Hern | Republican | exchange | 500K–1M |
| 2026-09-11 | Kevin Hern | Republican | exchange | 100K–250K |
| 2026-09-11 | Kevin Hern | Republican | exchange | 500K–1M |
| 2026-09-11 | Kevin Hern | Republican | exchange | 100K–250K |
| 2026-09-11 | Kevin Hern | Republican | exchange | 500K–1M |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $91.40 | -4.0% | $1.07 | $971 | -2.9% |
| 2 months | $92.43 | -5.1% | $1.07 | $961 | -3.9% |
| 3 months | $93.56 | -6.2% | $1.07 | $949 | -5.1% |
| 6 months | $91.90 | -4.6% | $2.14 | $978 | -2.2% |
| 1 year | $66.15 | +32.6% | $4.28 | $1,391 | +39.1% |
| 2 years | $101.83 | -13.9% | $8.40 | $944 | -5.6% |
| 3 years | $57.44 | +52.7% | $12.36 | $1,742 | +74.2% |
| 5 years | $47.00 | +86.7% | $19.92 | $2,290 | +129.0% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever OKE does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.